Supplement NDI Notification Guidance Cruel To Firms On Animal Testing

CFSAN’s latest draft guidance for NDI notifications does little to address the supplement industry’s concerns, and the “worst” aspect is a recommendation to test ingredients on animals when historical use data is not available, says a New Hope Network analyst.